Louise Kooij
Equibles does not estimate personal net worth.
About Louise Kooij
Earlier roles on record: Chief Accounting Officer at NewAmsterdam Pharma Co N.V. (NAMS) until August 31, 2026. NewAmsterdam Pharma Co N.V. reported in an 8-K filed April 24, 2026 that Louise Kooij was terminated as Chief Accounting Officer, effective August 31, 2026.
“On April 20, 2026, NewAmsterdam Pharma Company N.V. (the "Company") and Louise Kooij agreed that her employment as the Company's Chief Accounting Officer would end effective August 31, 2026 (the "Separation Date").”
Affiliation history
-
Start not stated–2026-08-31